ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag european medicines agency microbiology immunology

AstraZeneca, University of Oxford, vaccine, COVID-19, SARS-CoV-2, pandemic, coronavirus, vaccination, safety, Europe
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Asher Jones | Mar 12, 2021 | 2 min read
Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.
johnson & johnson johnson&johnson j&j janssen covid-19 vaccine vaccination pandemic adenovirus vector blood clot side effect cerebral venous sinus thrombosis CVST sars-cov-2 coronavirus pandemic astrazeneca
US Health Authorities Ask for Pause in J&J COVID-19 Vaccination
Kerry Grens | Apr 13, 2021 | 2 min read
The FDA and CDC are investigating a handful of reports of blood clots that occurred several days after people received the one-and-done shot.
RSV vaccine design concept art
RSV Vaccines That Work?
Rachael Moeller Gorman | Feb 16, 2023 | 10+ min read
Multiple candidates are in Phase 3 clinical trials for older adults and pregnant women, with some getting close to approval in the United States.
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
Wrestling with Recurrent Infections
Gayatri Vedantam and Glenn S. Tillotson | May 1, 2011 | 10+ min read
Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.
Collaborative Efforts Under Way To Combat Malaria
Alison Mack | May 11, 1997 | 8 min read
Sidebars Malaria: A Statistical Index Funding Agencies For Malaria Research Researchers in the field lament what they call gross underfunding, but say a joint approach will help ensure that avaliable monies are well spent. After several years of declining interest in malaria research and decreasing support for such studies, the field is gaining much-needed momentum. Spurred in part by an international conference held in Dakar, Senegal, in January, funding agencies and scientists around the gl
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
NIH Is Advised To Expand Its International Activities
Thomas Durso | Mar 2, 1997 | 9 min read
Sidebar: Advisory Panel's Recommendations to NIH But budget concerns may force the agency's heralded Fogarty Center to stand pat A comparatively small proposed budget increase for the center that coordinates international programs of the National Institutes of Health may prevent any significant expansion of its global efforts in the near future. A report submitted last fall by an external advisory panel recommended "a strengthening of international activities" at NIH (see list of recommendatio
Viral Soldiers
Jyoti Madhusoodanan | Jan 1, 2016 | 10+ min read
Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.
The Politics of Science
Anne Harding(aharding@the-scientist.com) | Jan 30, 2005 | 10+ min read
By many measures, 2004 was a tumultuous and high-profile year for science around the world.

Run a Search

ADVERTISEMENT